Pfizer Inc's chief executive, Albert Bourla, said on Wednesday he was confident that by the end of 2021 there would be more vaccine doses than required to fight the COVID-19 pandemic.
His remarks came after Britain approved a vaccine produced by Pfizer and its German biotechnology partner BioNTech on Wednesday. The two companies say their vaccine is 95% effective.